Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Milligan

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Endocrine|December 15, 2023
Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United StatesFrancis Worden, Olivera Rajkovic-Hooley, Neil Reynolds, et al.
Cardiology|October 13, 2010
The effects of isolated versus multiple lipid disorders on resource utilization among metabolic syndrome patients with lipid abnormalities despite Lipid-modifying treatmentBaishali Ambegaonkar, Diana Chirovsky, Wenchen Wu, et al.
International Journal of Clinical Practice|August 29, 2019
Impact of nocturia on patients' health-related quality of life and healthcare resource utilisation compared with OAB and BPH: Results from an observational survey in European and American patientsVeronica Y Zeng, Gary Milligan, James Piercy, et al.
Advances in Therapy|January 17, 2012
Fixed-dose combination antidiabetic therapy: real-world factors associated with prescribing choices and relationship with patient satisfaction and complianceMike Benford, Gary Milligan, James Pike, et al.
Respiratory Medicine|November 12, 2013
Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPDHenry Chrystyn, Mark Small, Gary Milligan, et al.
The Journal of Dermatology|July 12, 2023
Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real-world dataManabu Ohyama, Kazumasa Kamei, Akira Yuasa, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 19, 2013
Impact of night-time symptoms in COPD: a real-world study in five European countriesDavid Price, Mark Small, Gary Milligan, et al.
Breast (Edinburgh, Scotland)|November 5, 2018
Treatment patterns and clinical outcomes among patients receiving palbociclib in combination with an aromatase inhibitor or fulvestrant for HR+/HER2-negative advanced/metastatic breast cancer in real-world settings in the US: Results from the IRIS studyGavin Taylor-Stokes, Debanjali Mitra, John Waller, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 16, 2016
Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015Victoria Higgins, James Piercy, Adam Roughley, et al.
Headache|October 7, 2017
A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment PatternsJanet H Ford, James Jackson, Gary Milligan, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Endocrine|December 15, 2023
Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United StatesFrancis Worden, Olivera Rajkovic-Hooley, Neil Reynolds, et al.
Cardiology|October 13, 2010
The effects of isolated versus multiple lipid disorders on resource utilization among metabolic syndrome patients with lipid abnormalities despite Lipid-modifying treatmentBaishali Ambegaonkar, Diana Chirovsky, Wenchen Wu, et al.
International Journal of Clinical Practice|August 29, 2019
Impact of nocturia on patients' health-related quality of life and healthcare resource utilisation compared with OAB and BPH: Results from an observational survey in European and American patientsVeronica Y Zeng, Gary Milligan, James Piercy, et al.
Advances in Therapy|January 17, 2012
Fixed-dose combination antidiabetic therapy: real-world factors associated with prescribing choices and relationship with patient satisfaction and complianceMike Benford, Gary Milligan, James Pike, et al.
Respiratory Medicine|November 12, 2013
Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPDHenry Chrystyn, Mark Small, Gary Milligan, et al.
The Journal of Dermatology|July 12, 2023
Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real-world dataManabu Ohyama, Kazumasa Kamei, Akira Yuasa, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 19, 2013
Impact of night-time symptoms in COPD: a real-world study in five European countriesDavid Price, Mark Small, Gary Milligan, et al.
Breast (Edinburgh, Scotland)|November 5, 2018
Treatment patterns and clinical outcomes among patients receiving palbociclib in combination with an aromatase inhibitor or fulvestrant for HR+/HER2-negative advanced/metastatic breast cancer in real-world settings in the US: Results from the IRIS studyGavin Taylor-Stokes, Debanjali Mitra, John Waller, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 16, 2016
Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015Victoria Higgins, James Piercy, Adam Roughley, et al.
Headache|October 7, 2017
A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment PatternsJanet H Ford, James Jackson, Gary Milligan, et al.
Pageof 5